TeleCareSpot review
A separate consult fee applies and is credited toward the package if the patient is approved.
The verdict
TeleCareSpot publishes $299 a month for semaglutide and $399 for tirzepatide, flat at all doses with everything included. A separate $79 consult fee may be credited toward the package on approval. Coverage is 48 states.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 48
- From
- From $299/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
- Availability
- 48 states
TeleCareSpot sells both molecules by injection across 48 states. Both rates are flat at all doses. Oral tirzepatide and phentermine are also offered.
Who writes the prescription, and what do they see?
The consult is charged separately and then credited if approved. That prices the clinical step explicitly rather than folding it away.
Crediting the consult against the package is a fair structure. A reader who is declined pays for the assessment; a reader who is approved does not pay twice.
What happens when the dose goes up?
Both rates are flat at all doses, which answers the question directly. Nothing describes clinical support at a step.
What the price includes
Six months at $299 is $1,794 and tirzepatide at $399 is $2,394. Both totals hold at any dose. The consult is a $79 one-time fee, which the seller says may be applied toward an eligible program. A declined applicant is out $79.
What it claims, and what it cites
Both lines are compounded. A pharmacy prepares them. The FDA does not review them before dispensing. No pharmacy is named.
Where it holds up, and where it does not
- Strength: Flat at all doses on both molecules
- Strength: The consult fee is credited on approval
- Strength: Coverage across 48 states
- Strength: Everything included, no hidden fees stated
- Limitation: The credit applies only to an eligible program
- Limitation: A declined applicant pays it regardless
- Limitation: Oral tirzepatide is priced at intake only
- Limitation: No compounding pharmacy is named
What the evidence says about this kind of treatment
The assessment above is about TeleCareSpot. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader confident of approval who wants a flat all-in rate.
- Wrong for
- A reader who will not pay $79 before learning whether treatment is possible.
The evidence behind what TeleCareSpot prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How TeleCareSpot compares
| Seller | Who it suits | Go |
|---|---|---|
 TeleClinic | Readers who want the standard rate stated beside the introductory one before they sign up | See TeleClinic → |
 SurpassMD | Readers who will ask what their own approved figure is | See SurpassMD → |
 TMates | Readers choosing between formats who do not want the choice priced | See TMates → |
More GLP-1 telehealth sellers reviews: VitakeyVital StepVivanta CareVivioMDwelludr.Yes Clinic
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Do I pay for the consult?
- It is charged separately and credited toward the package if you are approved.
- How much is the consult?
- $79, one time. The seller says the fee may be applied toward an eligible treatment program.
- Does the price rise with the dose?
- No. Both rates are stated flat at all doses.
- Is TeleCareSpot legit?
- TeleCareSpot is a GLP-1 telehealth sellers service. Its stated availability: 48 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay.
- Is TeleCareSpot expensive compared with other GLP-1 telehealth sellers?
- TeleCareSpot publishes a starting figure of $299/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts TeleCareSpot above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.